Quantitative analysis of the respiratory lab sector reveals a clear correlation between the number of active inhalation drug clinical trials and the sales of preclinical hardware. By tracking the pipeline of drugs in Phase I and II, equipment manufacturers can predict demand for the next generation of testing tools. Currently, the data shows a spike in research targeting rare lung diseases,...